Patent · US Active

Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies

US8987218B2 · kind B2 · utility

12Cited by

5References

14Claims

0Family size

Assignee

Galderma Holding SA · CH

Inventors

Alexandre KAOUKHOV · Newport Beach, US
Christophe Villard · Le Tignet, FR
Philippe BOUISSOU · Valbonne, FR

Key dates

Filing date	Dec 17, 2012
Grant date	Mar 24, 2015
Priority date	—
Expiry date	Dec 17, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P33/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.